Tech Blog: NASH Diagnostic Discovered

Tech Launch Arizona

With funds from the National Institute of Health, Dr. Nathan Cherrington, UArizona College of Pharmacy Associate Dean for Research and Graduate Studies and BIO5 member, has created a non-invasive diagnostic to determine if someone has Nonalcoholic Steatohepatitis (NASH). NASH is a chronic liver disease that irregulates the function of the liver and affects an estimated 30 to 50 million patients, with only around 300,000 of them being properly diagnosed. Currently, the only diagnosis for NASH includes a painful liver biopsy, which can result in heavy blood loss.